nodes	percent_of_prediction	percent_of_DWPC	metapath
Labetalol—Lisdexamfetamine—Lisinopril—systemic scleroderma	0.295	0.377	CrCrCtD
Labetalol—Quinapril—Lisinopril—systemic scleroderma	0.249	0.319	CrCrCtD
Labetalol—Benazepril—Lisinopril—systemic scleroderma	0.238	0.304	CrCrCtD
Labetalol—Quinapril—ACE—systemic scleroderma	0.00134	0.535	CrCbGaD
Labetalol—Benazepril—ACE—systemic scleroderma	0.00117	0.465	CrCbGaD
Labetalol—Feeling abnormal—Captopril—systemic scleroderma	0.000342	0.00158	CcSEcCtD
Labetalol—Vision blurred—Lisinopril—systemic scleroderma	0.000339	0.00157	CcSEcCtD
Labetalol—Gastrointestinal pain—Captopril—systemic scleroderma	0.000339	0.00157	CcSEcCtD
Labetalol—Asthenia—Mometasone—systemic scleroderma	0.000339	0.00157	CcSEcCtD
Labetalol—Hypotension—Azathioprine—systemic scleroderma	0.000339	0.00157	CcSEcCtD
Labetalol—Tremor—Lisinopril—systemic scleroderma	0.000337	0.00156	CcSEcCtD
Labetalol—Mood swings—Prednisone—systemic scleroderma	0.000337	0.00156	CcSEcCtD
Labetalol—Discomfort—Mycophenolic acid—systemic scleroderma	0.000336	0.00156	CcSEcCtD
Labetalol—Pruritus—Mometasone—systemic scleroderma	0.000334	0.00155	CcSEcCtD
Labetalol—Ill-defined disorder—Lisinopril—systemic scleroderma	0.000334	0.00155	CcSEcCtD
Labetalol—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000331	0.00153	CcSEcCtD
Labetalol—Angioedema—Lisinopril—systemic scleroderma	0.000329	0.00152	CcSEcCtD
Labetalol—Confusional state—Mycophenolic acid—systemic scleroderma	0.000329	0.00152	CcSEcCtD
Labetalol—Abdominal pain—Captopril—systemic scleroderma	0.000328	0.00152	CcSEcCtD
Labetalol—Body temperature increased—Captopril—systemic scleroderma	0.000328	0.00152	CcSEcCtD
Labetalol—Oedema—Mycophenolic acid—systemic scleroderma	0.000326	0.00151	CcSEcCtD
Labetalol—Nausea—Pentoxifylline—systemic scleroderma	0.000325	0.00151	CcSEcCtD
Labetalol—Malaise—Lisinopril—systemic scleroderma	0.000325	0.0015	CcSEcCtD
Labetalol—Vertigo—Lisinopril—systemic scleroderma	0.000324	0.0015	CcSEcCtD
Labetalol—Diarrhoea—Mometasone—systemic scleroderma	0.000323	0.0015	CcSEcCtD
Labetalol—Syncope—Lisinopril—systemic scleroderma	0.000323	0.0015	CcSEcCtD
Labetalol—Shock—Mycophenolic acid—systemic scleroderma	0.000321	0.00149	CcSEcCtD
Labetalol—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.00032	0.00148	CcSEcCtD
Labetalol—Hypotension—Leflunomide—systemic scleroderma	0.00032	0.00148	CcSEcCtD
Labetalol—Palpitations—Lisinopril—systemic scleroderma	0.000318	0.00147	CcSEcCtD
Labetalol—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.000318	0.00147	CcSEcCtD
Labetalol—Loss of consciousness—Lisinopril—systemic scleroderma	0.000317	0.00147	CcSEcCtD
Labetalol—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000316	0.00146	CcSEcCtD
Labetalol—Paraesthesia—Leflunomide—systemic scleroderma	0.000307	0.00142	CcSEcCtD
Labetalol—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.000307	0.00142	CcSEcCtD
Labetalol—Dyspnoea—Leflunomide—systemic scleroderma	0.000305	0.00141	CcSEcCtD
Labetalol—Hypotension—Mycophenolic acid—systemic scleroderma	0.000305	0.00141	CcSEcCtD
Labetalol—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000303	0.00141	CcSEcCtD
Labetalol—Discomfort—Lisinopril—systemic scleroderma	0.000303	0.0014	CcSEcCtD
Labetalol—Lethargy—Methotrexate—systemic scleroderma	0.000303	0.0014	CcSEcCtD
Labetalol—Dyspepsia—Leflunomide—systemic scleroderma	0.000301	0.00139	CcSEcCtD
Labetalol—Vomiting—Mometasone—systemic scleroderma	0.000301	0.00139	CcSEcCtD
Labetalol—Sweating increased—Prednisone—systemic scleroderma	0.000299	0.00138	CcSEcCtD
Labetalol—Feeling abnormal—Azathioprine—systemic scleroderma	0.000299	0.00138	CcSEcCtD
Labetalol—Rash—Mometasone—systemic scleroderma	0.000298	0.00138	CcSEcCtD
Labetalol—Asthenia—Captopril—systemic scleroderma	0.000298	0.00138	CcSEcCtD
Labetalol—Dermatitis—Mometasone—systemic scleroderma	0.000298	0.00138	CcSEcCtD
Labetalol—Confusional state—Lisinopril—systemic scleroderma	0.000296	0.00137	CcSEcCtD
Labetalol—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000296	0.00137	CcSEcCtD
Labetalol—Headache—Mometasone—systemic scleroderma	0.000296	0.00137	CcSEcCtD
Labetalol—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000296	0.00137	CcSEcCtD
Labetalol—Fatigue—Leflunomide—systemic scleroderma	0.000295	0.00137	CcSEcCtD
Labetalol—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000294	0.00136	CcSEcCtD
Labetalol—Oedema—Lisinopril—systemic scleroderma	0.000294	0.00136	CcSEcCtD
Labetalol—Pruritus—Captopril—systemic scleroderma	0.000294	0.00136	CcSEcCtD
Labetalol—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000293	0.00136	CcSEcCtD
Labetalol—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000293	0.00136	CcSEcCtD
Labetalol—Pain—Leflunomide—systemic scleroderma	0.000293	0.00135	CcSEcCtD
Labetalol—Constipation—Leflunomide—systemic scleroderma	0.000293	0.00135	CcSEcCtD
Labetalol—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000291	0.00135	CcSEcCtD
Labetalol—Somnolence—Mycophenolic acid—systemic scleroderma	0.00029	0.00134	CcSEcCtD
Labetalol—Shock—Lisinopril—systemic scleroderma	0.000289	0.00134	CcSEcCtD
Labetalol—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000288	0.00134	CcSEcCtD
Labetalol—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000287	0.00133	CcSEcCtD
Labetalol—Body temperature increased—Azathioprine—systemic scleroderma	0.000286	0.00133	CcSEcCtD
Labetalol—Abdominal pain—Azathioprine—systemic scleroderma	0.000286	0.00133	CcSEcCtD
Labetalol—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000285	0.00132	CcSEcCtD
Labetalol—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000284	0.00132	CcSEcCtD
Labetalol—Diarrhoea—Captopril—systemic scleroderma	0.000284	0.00132	CcSEcCtD
Labetalol—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000284	0.00131	CcSEcCtD
Labetalol—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000283	0.00131	CcSEcCtD
Labetalol—Erectile dysfunction—Prednisone—systemic scleroderma	0.000283	0.00131	CcSEcCtD
Labetalol—Feeling abnormal—Leflunomide—systemic scleroderma	0.000282	0.00131	CcSEcCtD
Labetalol—Fatigue—Mycophenolic acid—systemic scleroderma	0.000281	0.0013	CcSEcCtD
Labetalol—Mood swings—Methotrexate—systemic scleroderma	0.000281	0.0013	CcSEcCtD
Labetalol—Nausea—Mometasone—systemic scleroderma	0.000281	0.0013	CcSEcCtD
Labetalol—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00028	0.0013	CcSEcCtD
Labetalol—Pain—Mycophenolic acid—systemic scleroderma	0.000279	0.00129	CcSEcCtD
Labetalol—Constipation—Mycophenolic acid—systemic scleroderma	0.000279	0.00129	CcSEcCtD
Labetalol—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000279	0.00129	CcSEcCtD
Labetalol—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000277	0.00128	CcSEcCtD
Labetalol—Hypotension—Lisinopril—systemic scleroderma	0.000275	0.00127	CcSEcCtD
Labetalol—Dizziness—Captopril—systemic scleroderma	0.000275	0.00127	CcSEcCtD
Labetalol—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000274	0.00127	CcSEcCtD
Labetalol—Depression—Prednisone—systemic scleroderma	0.000273	0.00126	CcSEcCtD
Labetalol—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000272	0.00126	CcSEcCtD
Labetalol—Urticaria—Leflunomide—systemic scleroderma	0.000272	0.00126	CcSEcCtD
Labetalol—Abdominal pain—Leflunomide—systemic scleroderma	0.00027	0.00125	CcSEcCtD
Labetalol—Body temperature increased—Leflunomide—systemic scleroderma	0.00027	0.00125	CcSEcCtD
Labetalol—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000269	0.00125	CcSEcCtD
Labetalol—Hypersensitivity—Azathioprine—systemic scleroderma	0.000267	0.00124	CcSEcCtD
Labetalol—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000267	0.00124	CcSEcCtD
Labetalol—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000265	0.00123	CcSEcCtD
Labetalol—Paraesthesia—Lisinopril—systemic scleroderma	0.000264	0.00122	CcSEcCtD
Labetalol—Vomiting—Captopril—systemic scleroderma	0.000264	0.00122	CcSEcCtD
Labetalol—Dyspnoea—Lisinopril—systemic scleroderma	0.000262	0.00121	CcSEcCtD
Labetalol—Rash—Captopril—systemic scleroderma	0.000262	0.00121	CcSEcCtD
Labetalol—Dermatitis—Captopril—systemic scleroderma	0.000261	0.00121	CcSEcCtD
Labetalol—Somnolence—Lisinopril—systemic scleroderma	0.000261	0.00121	CcSEcCtD
Labetalol—Headache—Captopril—systemic scleroderma	0.00026	0.0012	CcSEcCtD
Labetalol—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00026	0.0012	CcSEcCtD
Labetalol—Dyspepsia—Lisinopril—systemic scleroderma	0.000259	0.0012	CcSEcCtD
Labetalol—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000258	0.00119	CcSEcCtD
Labetalol—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000258	0.00119	CcSEcCtD
Labetalol—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000258	0.00119	CcSEcCtD
Labetalol—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000258	0.00119	CcSEcCtD
Labetalol—Fatigue—Lisinopril—systemic scleroderma	0.000253	0.00117	CcSEcCtD
Labetalol—Shock—Mycophenolate mofetil—systemic scleroderma	0.000253	0.00117	CcSEcCtD
Labetalol—Hypersensitivity—Leflunomide—systemic scleroderma	0.000252	0.00117	CcSEcCtD
Labetalol—Pain—Lisinopril—systemic scleroderma	0.000251	0.00116	CcSEcCtD
Labetalol—Constipation—Lisinopril—systemic scleroderma	0.000251	0.00116	CcSEcCtD
Labetalol—Bradycardia—Prednisone—systemic scleroderma	0.00025	0.00116	CcSEcCtD
Labetalol—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000249	0.00115	CcSEcCtD
Labetalol—Diarrhoea—Azathioprine—systemic scleroderma	0.000248	0.00115	CcSEcCtD
Labetalol—Nausea—Captopril—systemic scleroderma	0.000247	0.00114	CcSEcCtD
Labetalol—Asthenia—Leflunomide—systemic scleroderma	0.000245	0.00114	CcSEcCtD
Labetalol—Hallucination—Prednisone—systemic scleroderma	0.000245	0.00113	CcSEcCtD
Labetalol—Feeling abnormal—Lisinopril—systemic scleroderma	0.000242	0.00112	CcSEcCtD
Labetalol—Pruritus—Leflunomide—systemic scleroderma	0.000242	0.00112	CcSEcCtD
Labetalol—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000241	0.00111	CcSEcCtD
Labetalol—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00024	0.00111	CcSEcCtD
Labetalol—Dysuria—Methotrexate—systemic scleroderma	0.00024	0.00111	CcSEcCtD
Labetalol—Dizziness—Azathioprine—systemic scleroderma	0.00024	0.00111	CcSEcCtD
Labetalol—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000236	0.00109	CcSEcCtD
Labetalol—Asthenia—Mycophenolic acid—systemic scleroderma	0.000234	0.00108	CcSEcCtD
Labetalol—Diarrhoea—Leflunomide—systemic scleroderma	0.000234	0.00108	CcSEcCtD
Labetalol—Urticaria—Lisinopril—systemic scleroderma	0.000234	0.00108	CcSEcCtD
Labetalol—Abdominal pain—Lisinopril—systemic scleroderma	0.000232	0.00108	CcSEcCtD
Labetalol—Body temperature increased—Lisinopril—systemic scleroderma	0.000232	0.00108	CcSEcCtD
Labetalol—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000231	0.00107	CcSEcCtD
Labetalol—Pruritus—Mycophenolic acid—systemic scleroderma	0.000231	0.00107	CcSEcCtD
Labetalol—Vomiting—Azathioprine—systemic scleroderma	0.00023	0.00107	CcSEcCtD
Labetalol—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00023	0.00106	CcSEcCtD
Labetalol—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000229	0.00106	CcSEcCtD
Labetalol—Drowsiness—Methotrexate—systemic scleroderma	0.000229	0.00106	CcSEcCtD
Labetalol—Rash—Azathioprine—systemic scleroderma	0.000228	0.00106	CcSEcCtD
Labetalol—Dermatitis—Azathioprine—systemic scleroderma	0.000228	0.00106	CcSEcCtD
Labetalol—Depression—Methotrexate—systemic scleroderma	0.000228	0.00106	CcSEcCtD
Labetalol—Flushing—Prednisone—systemic scleroderma	0.000228	0.00106	CcSEcCtD
Labetalol—Headache—Azathioprine—systemic scleroderma	0.000227	0.00105	CcSEcCtD
Labetalol—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000227	0.00105	CcSEcCtD
Labetalol—Dizziness—Leflunomide—systemic scleroderma	0.000226	0.00105	CcSEcCtD
Labetalol—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000223	0.00103	CcSEcCtD
Labetalol—Pain—Mycophenolate mofetil—systemic scleroderma	0.00022	0.00102	CcSEcCtD
Labetalol—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00022	0.00102	CcSEcCtD
Labetalol—Sweating—Methotrexate—systemic scleroderma	0.000219	0.00102	CcSEcCtD
Labetalol—Vomiting—Leflunomide—systemic scleroderma	0.000218	0.00101	CcSEcCtD
Labetalol—Alopecia—Prednisone—systemic scleroderma	0.000217	0.00101	CcSEcCtD
Labetalol—Hypersensitivity—Lisinopril—systemic scleroderma	0.000217	0.001	CcSEcCtD
Labetalol—Dizziness—Mycophenolic acid—systemic scleroderma	0.000216	0.000999	CcSEcCtD
Labetalol—Epistaxis—Methotrexate—systemic scleroderma	0.000216	0.000999	CcSEcCtD
Labetalol—Rash—Leflunomide—systemic scleroderma	0.000216	0.000999	CcSEcCtD
Labetalol—Dermatitis—Leflunomide—systemic scleroderma	0.000216	0.000998	CcSEcCtD
Labetalol—Mental disorder—Prednisone—systemic scleroderma	0.000215	0.000997	CcSEcCtD
Labetalol—Nausea—Azathioprine—systemic scleroderma	0.000215	0.000996	CcSEcCtD
Labetalol—Headache—Leflunomide—systemic scleroderma	0.000214	0.000992	CcSEcCtD
Labetalol—Erythema—Prednisone—systemic scleroderma	0.000214	0.000991	CcSEcCtD
Labetalol—Agranulocytosis—Methotrexate—systemic scleroderma	0.000214	0.000989	CcSEcCtD
Labetalol—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000212	0.000983	CcSEcCtD
Labetalol—Asthenia—Lisinopril—systemic scleroderma	0.000211	0.000977	CcSEcCtD
Labetalol—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000211	0.000975	CcSEcCtD
Labetalol—Pruritus—Lisinopril—systemic scleroderma	0.000208	0.000963	CcSEcCtD
Labetalol—Vomiting—Mycophenolic acid—systemic scleroderma	0.000208	0.000961	CcSEcCtD
Labetalol—Rash—Mycophenolic acid—systemic scleroderma	0.000206	0.000953	CcSEcCtD
Labetalol—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000206	0.000952	CcSEcCtD
Labetalol—Hepatitis—Methotrexate—systemic scleroderma	0.000205	0.000951	CcSEcCtD
Labetalol—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000205	0.000948	CcSEcCtD
Labetalol—Headache—Mycophenolic acid—systemic scleroderma	0.000204	0.000947	CcSEcCtD
Labetalol—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000204	0.000943	CcSEcCtD
Labetalol—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000204	0.000943	CcSEcCtD
Labetalol—Nausea—Leflunomide—systemic scleroderma	0.000203	0.000941	CcSEcCtD
Labetalol—Vision blurred—Prednisone—systemic scleroderma	0.000202	0.000934	CcSEcCtD
Labetalol—Diarrhoea—Lisinopril—systemic scleroderma	0.000201	0.000931	CcSEcCtD
Labetalol—Ill-defined disorder—Prednisone—systemic scleroderma	0.000198	0.000919	CcSEcCtD
Labetalol—Visual impairment—Methotrexate—systemic scleroderma	0.000198	0.000917	CcSEcCtD
Labetalol—Angioedema—Prednisone—systemic scleroderma	0.000195	0.000905	CcSEcCtD
Labetalol—Dizziness—Lisinopril—systemic scleroderma	0.000194	0.0009	CcSEcCtD
Labetalol—Nausea—Mycophenolic acid—systemic scleroderma	0.000194	0.000898	CcSEcCtD
Labetalol—Malaise—Prednisone—systemic scleroderma	0.000193	0.000893	CcSEcCtD
Labetalol—Vertigo—Prednisone—systemic scleroderma	0.000192	0.00089	CcSEcCtD
Labetalol—Syncope—Prednisone—systemic scleroderma	0.000192	0.000888	CcSEcCtD
Labetalol—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00019	0.000879	CcSEcCtD
Labetalol—Loss of consciousness—Prednisone—systemic scleroderma	0.000188	0.000871	CcSEcCtD
Labetalol—Vomiting—Lisinopril—systemic scleroderma	0.000187	0.000866	CcSEcCtD
Labetalol—Rash—Lisinopril—systemic scleroderma	0.000185	0.000858	CcSEcCtD
Labetalol—Dermatitis—Lisinopril—systemic scleroderma	0.000185	0.000858	CcSEcCtD
Labetalol—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000185	0.000856	CcSEcCtD
Labetalol—Hypertension—Prednisone—systemic scleroderma	0.000185	0.000855	CcSEcCtD
Labetalol—Headache—Lisinopril—systemic scleroderma	0.000184	0.000853	CcSEcCtD
Labetalol—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000182	0.000844	CcSEcCtD
Labetalol—Alopecia—Methotrexate—systemic scleroderma	0.000181	0.00084	CcSEcCtD
Labetalol—Discomfort—Prednisone—systemic scleroderma	0.00018	0.000833	CcSEcCtD
Labetalol—Mental disorder—Methotrexate—systemic scleroderma	0.00018	0.000833	CcSEcCtD
Labetalol—Erythema—Methotrexate—systemic scleroderma	0.000179	0.000828	CcSEcCtD
Labetalol—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000176	0.000816	CcSEcCtD
Labetalol—Nausea—Lisinopril—systemic scleroderma	0.000175	0.000809	CcSEcCtD
Labetalol—Oedema—Prednisone—systemic scleroderma	0.000175	0.000808	CcSEcCtD
Labetalol—Anaphylactic shock—Prednisone—systemic scleroderma	0.000175	0.000808	CcSEcCtD
Labetalol—Shock—Prednisone—systemic scleroderma	0.000172	0.000795	CcSEcCtD
Labetalol—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00017	0.000789	CcSEcCtD
Labetalol—Hyperhidrosis—Prednisone—systemic scleroderma	0.000169	0.000782	CcSEcCtD
Labetalol—Vision blurred—Methotrexate—systemic scleroderma	0.000168	0.00078	CcSEcCtD
Labetalol—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000166	0.000768	CcSEcCtD
Labetalol—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000164	0.000758	CcSEcCtD
Labetalol—Rash—Mycophenolate mofetil—systemic scleroderma	0.000162	0.000752	CcSEcCtD
Labetalol—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000162	0.000751	CcSEcCtD
Labetalol—Headache—Mycophenolate mofetil—systemic scleroderma	0.000161	0.000747	CcSEcCtD
Labetalol—Malaise—Methotrexate—systemic scleroderma	0.000161	0.000747	CcSEcCtD
Labetalol—Vertigo—Methotrexate—systemic scleroderma	0.000161	0.000744	CcSEcCtD
Labetalol—Paraesthesia—Prednisone—systemic scleroderma	0.000157	0.000726	CcSEcCtD
Labetalol—Dyspepsia—Prednisone—systemic scleroderma	0.000154	0.000712	CcSEcCtD
Labetalol—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000153	0.000708	CcSEcCtD
Labetalol—Fatigue—Prednisone—systemic scleroderma	0.000151	0.000697	CcSEcCtD
Labetalol—Discomfort—Methotrexate—systemic scleroderma	0.00015	0.000696	CcSEcCtD
Labetalol—Constipation—Prednisone—systemic scleroderma	0.000149	0.000691	CcSEcCtD
Labetalol—Confusional state—Methotrexate—systemic scleroderma	0.000147	0.000681	CcSEcCtD
Labetalol—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000146	0.000676	CcSEcCtD
Labetalol—Feeling abnormal—Prednisone—systemic scleroderma	0.000144	0.000666	CcSEcCtD
Labetalol—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000143	0.000661	CcSEcCtD
Labetalol—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000141	0.000653	CcSEcCtD
Labetalol—Urticaria—Prednisone—systemic scleroderma	0.000139	0.000642	CcSEcCtD
Labetalol—Abdominal pain—Prednisone—systemic scleroderma	0.000138	0.000639	CcSEcCtD
Labetalol—Body temperature increased—Prednisone—systemic scleroderma	0.000138	0.000639	CcSEcCtD
Labetalol—Hypotension—Methotrexate—systemic scleroderma	0.000136	0.000631	CcSEcCtD
Labetalol—Paraesthesia—Methotrexate—systemic scleroderma	0.000131	0.000607	CcSEcCtD
Labetalol—Dyspnoea—Methotrexate—systemic scleroderma	0.00013	0.000602	CcSEcCtD
Labetalol—Somnolence—Methotrexate—systemic scleroderma	0.00013	0.000601	CcSEcCtD
Labetalol—Hypersensitivity—Prednisone—systemic scleroderma	0.000129	0.000596	CcSEcCtD
Labetalol—Dyspepsia—Methotrexate—systemic scleroderma	0.000128	0.000595	CcSEcCtD
Labetalol—Fatigue—Methotrexate—systemic scleroderma	0.000126	0.000583	CcSEcCtD
Labetalol—Asthenia—Prednisone—systemic scleroderma	0.000125	0.00058	CcSEcCtD
Labetalol—Pain—Methotrexate—systemic scleroderma	0.000125	0.000578	CcSEcCtD
Labetalol—Pruritus—Prednisone—systemic scleroderma	0.000124	0.000572	CcSEcCtD
Labetalol—Feeling abnormal—Methotrexate—systemic scleroderma	0.00012	0.000557	CcSEcCtD
Labetalol—Diarrhoea—Prednisone—systemic scleroderma	0.000119	0.000553	CcSEcCtD
Labetalol—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000119	0.000553	CcSEcCtD
Labetalol—Urticaria—Methotrexate—systemic scleroderma	0.000116	0.000537	CcSEcCtD
Labetalol—Dizziness—Prednisone—systemic scleroderma	0.000115	0.000535	CcSEcCtD
Labetalol—Abdominal pain—Methotrexate—systemic scleroderma	0.000115	0.000534	CcSEcCtD
Labetalol—Body temperature increased—Methotrexate—systemic scleroderma	0.000115	0.000534	CcSEcCtD
Labetalol—Vomiting—Prednisone—systemic scleroderma	0.000111	0.000514	CcSEcCtD
Labetalol—Rash—Prednisone—systemic scleroderma	0.00011	0.00051	CcSEcCtD
Labetalol—Dermatitis—Prednisone—systemic scleroderma	0.00011	0.000509	CcSEcCtD
Labetalol—Headache—Prednisone—systemic scleroderma	0.000109	0.000506	CcSEcCtD
Labetalol—Hypersensitivity—Methotrexate—systemic scleroderma	0.000108	0.000498	CcSEcCtD
Labetalol—Asthenia—Methotrexate—systemic scleroderma	0.000105	0.000485	CcSEcCtD
Labetalol—Nausea—Prednisone—systemic scleroderma	0.000104	0.00048	CcSEcCtD
Labetalol—Pruritus—Methotrexate—systemic scleroderma	0.000103	0.000478	CcSEcCtD
Labetalol—Diarrhoea—Methotrexate—systemic scleroderma	9.98e-05	0.000462	CcSEcCtD
Labetalol—Dizziness—Methotrexate—systemic scleroderma	9.65e-05	0.000447	CcSEcCtD
Labetalol—Vomiting—Methotrexate—systemic scleroderma	9.28e-05	0.00043	CcSEcCtD
Labetalol—Rash—Methotrexate—systemic scleroderma	9.2e-05	0.000426	CcSEcCtD
Labetalol—Dermatitis—Methotrexate—systemic scleroderma	9.19e-05	0.000426	CcSEcCtD
Labetalol—Headache—Methotrexate—systemic scleroderma	9.14e-05	0.000423	CcSEcCtD
Labetalol—Nausea—Methotrexate—systemic scleroderma	8.67e-05	0.000401	CcSEcCtD
